Results 131 to 140 of about 1,002,895 (267)

Cost‐effectiveness of low dose colchicine prophylaxis when starting allopurinol using the “start‐low go‐slow” approach for gout: evidence from a non‐inferiority randomised double‐blind placebo‐controlled trial.

Arthritis Care &Research, Accepted Article.
Objective The aim of this study was to investigate the cost‐effectiveness of low‐dose colchicine prophylaxis for preventing gout flares when starting allopurinol using the “start‐low go‐slow” approach. Methods Participants with gout, fulfilling the American College of Rheumatology recommendations for starting urate‐lowering therapy and with serum urate
Yana Pryymachenko, Ross Wilson, Nicola Dalbeth, J. Haxby Abbott, Lisa Stamp   +4 more
wiley   +1 more source

Enhancing pharmacology education through role-play: impact on student attitudes. [PDF]

BMC Med Educ
Tekeş E, Güngör B, Sılan C, Toraman Ç.   +3 more
europepmc   +1 more source

Phytochemical Analysis of Semen Hoveniae and Its Potential Mechanism Against Alcoholic Liver Disease via an Integrated Approach Combining UHPLC‐Q‐TOF MS, Network Pharmacology, and Molecular Docking [PDF]

Min Li, Zhuo‐chun Wei, Feng‐Xiang Zhang, Haijun Li   +3 more
openalex   +1 more source

Considerations for Issues of Regression to the Mean and Contextual Effects in Clinical Trials for Pain in Rheumatic Diseases

Arthritis Care &Research, EarlyView.
Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. Although pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain ...
Yen T. Chen, Guohao Zhu, Afton L. Hassett, Daniel Clauw, Susan L. Murphy   +4 more
wiley   +1 more source

Correction: Psychiatric adverse events associated with infliximab: a cohort study from the French nationwide discharge abstract database. [PDF]

Front Pharmacol
Thillard EM, Gautier S, Babykina E, Carton L, Amad A, Bouzillé G, Beuscart JB, Chazard E.   +7 more
europepmc   +1 more source

Simulation and Machine Learning Assessment of P-Glycoprotein Pharmacology in the Blood–Brain Barrier: Inhibition and Substrate Transport [PDF]

Christian Jorgensen, Elizabeth Oliphant, Michael J. Barker, Eduardo López, Saaihasamreen Thulasi, Helmut Prior, Ben William Franey, C D Gregory, Jerry Oluwasegun, Anjalee Ajay, Roger R. Draheim   +10 more
openalex   +1 more source

Clinical Outcomes Of Patients Within The Rheumatoid Arthritis Care Pathway Cohort At a Tertiary Care Integrated Delivery Network: A Comparison To Usual Care

Arthritis Care &Research, Accepted Article.
Objective We aimed to compare clinical outcomes between patients in the Allegheny Health Network rheumatoid arthritis (RA) care pathway and patients receiving usual care. Methods The care pathway initiative implements guideline‐based best practice alongside multi‐disciplinary team‐based care. Clinical and insurance claims data were extracted to compare
Tarun Sharma, Tyson S. Barrett, Teigan Dwyer, Nancy Campbell, Jessica Heintzinger, Ellen Kraemer, Adam Dore, Susan Manzi   +7 more
wiley   +1 more source

Pain-Causing Venom Peptides: Insights into Sensory Neuron Pharmacology [PDF]

, 2017
Sina Jami, Andelain Erickson, Stuart M. Brierley, Irina Vetter   +3 more
openalex   +1 more source

Association Between Discordance of Disease Activity Indices and Quantitative Sensory Testing Measures of Nociplastic Pain in Patients With Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective This study investigates the association between discordance in commonly collected clinical indicators of rheumatoid arthritis (RA) disease activity and abnormalities in quantitative sensory testing (QST) observed in individuals with nociplastic pain.
Clarice P. Lin, Burcu Aydemir, Jing Song, Lutfiyya N. Muhammad, Tuhina Neogi, Wendy Marder, Clifton O. Bingham, Marcy B. Bolster, Daniel J. Clauw, Dorothy D. Dunlop, Yvonne C. Lee   +10 more
wiley   +1 more source

Human-Based Technologies in Cardiovascular Pharmacology Research. [PDF]

J Cardiovasc Pharmacol
Biondi-Zoccai G, Frati G, Carnevale R, Booz GW.   +3 more
europepmc   +1 more source